7Baggers
 ProQR Therapeutics (NASDAQ:PRQR) Raised to Hold at Zacks Research  MarketBeat Sun, 16 Nov 2025 16:11:44 GMT
 Published on: 2025-11-16 01:11:58  newser.com Sun, 16 Nov 2025 07:11:58 GMT
 Published on: 2025-11-15 09:12:09  newser.com Sat, 15 Nov 2025 15:12:09 GMT
 published on: 2025-11-15 03:03:47  newser.com Sat, 15 Nov 2025 09:03:47 GMT
 Published on: 2025-11-15 01:18:18  newser.com Sat, 15 Nov 2025 07:18:18 GMT
 published on: 2025-11-14 21:16:24  newser.com Sat, 15 Nov 2025 03:16:24 GMT
 published on: 2025-11-14 18:40:18  newser.com Sat, 15 Nov 2025 00:40:18 GMT
 published on: 2025-11-13 10:10:57  newser.com Thu, 13 Nov 2025 16:10:57 GMT
 published on: 2025-11-10 20:25:41  newser.com Tue, 11 Nov 2025 02:25:41 GMT
 published on: 2025-11-09 22:11:52  newser.com Mon, 10 Nov 2025 04:11:52 GMT
 published on: 2025-11-09 14:05:04  newser.com Sun, 09 Nov 2025 20:05:04 GMT
 published on: 2025-11-07 00:41:32  newser.com Fri, 07 Nov 2025 06:41:32 GMT
 proqr (prqr) reports q3 loss, misses revenue estimates  sharewise.com Fri, 07 Nov 2025 04:44:07 GMT
 proqr: q3 earnings snapshot  Norwalk Hour Fri, 07 Nov 2025 00:47:24 GMT
 ProQR Reports Loss But Analysts See Big Upside Ahead  Finimize Thu, 06 Nov 2025 17:21:44 GMT
 ProQR Reports Q3 2025 Financial Results Amid Revenue Decline  TipRanks Thu, 06 Nov 2025 12:59:06 GMT
 proqr q3 revenue misses estimates, reports net loss  MarketScreener Thu, 06 Nov 2025 12:19:38 GMT
 proqr: q3 earnings snapshot  Barchart.com Thu, 06 Nov 2025 12:08:53 GMT
 brief-proqr therapeutics q3 eps eur -0.1  TradingView Thu, 06 Nov 2025 12:00:45 GMT
 ProQR Announces Third Quarter 2025 Operating and Financial Results  GlobeNewswire Thu, 06 Nov 2025 12:00:00 GMT
 ProQR Therapeutics NV earnings beat, revenue fell short of estimates  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates  Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
 Is ProQR Therapeutics (NASDAQ:PRQR) Using Debt Sensibly?  simplywall.st Wed, 05 Nov 2025 08:00:00 GMT

ProQR Therapeutics N.V
(NASDAQ:PRQR) 

PRQR stock logo

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It is primarily developing sepofarsen that is in phase II/III illuminate trial for treating leber's congenital amaurosis 10 disease; QR-421...

Founded: 2012
Full Time Employees: 154
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends